Loading clinical trials...
Loading clinical trials...
Implanting a ventricular assist device (VAD) is a promising therapy for end-stage cardiac failure. However, the implantation of these devices is associated with a high risk of severe hemorrhages and m...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Strasbourg, France
NCT06299176 · Heart Failure NYHA Class III, Heart Failure NYHA Class IV, and more
NCT04117295 · End-stage Heart Failure
NCT06345521 · Heart Failure, Congenital, and more
NCT06063811 · Ventricular Tachycardia, End-stage Heart Failure, and more
NCT04293575 · Heart Failure, Mitral Regurgitation, and more
Hopitaux Universitaire de Strasbourg
Strasbourg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions